SUPPORTED BY
Digital transformation has had significant support amongst our executive leadership. The last 18 months has also seen considerable investment being made in technology, upskilling and processes to ensure our labs are fit for modern biopharma research.
However, we are still facing some fundamental challenges in transitioning to a truly digital and data driven industry. Not least are legacy systems, poor data quality, disconnected datasets, lack of skills and archaic, siloed, working practices.
How are our leaders addressing these important challenges and what lessons have they learnt from their own internal initiatives? More importantly, what advice and guidance can they give us to ensure that our scientists have the tools at their fingertips to allow them to innovate in a digital world.
Delegates are invited to join moderated working groups on topical subjects. Round tables are available for in-person attendees only.
Leading pharmaceutical companies take us through key elements of their research digitalization programs.
How do we transform and maintain systems, data, processes and cross function information architecture to provide a robust information ecosystem that allows us to get more from our data?
Includes exciting new case studies.
The benefits of a fully integrated, automated and connected lab are obvious. They include the ability to remotely perform experiments, decrease the rate of error in reproducibility and increase data security and the overall security of the lab.
How does the modern life science organization implement a connected lab strategy? What are the new technologies underpinning the connected lab and how are they transforming the way science is done? What are the barriers to adoption? What are the analytical tools that we can apply to experimental data to get insights previously unavailable to us?
What are the new developments in workspace design and what has changed since the pandemic and the resultant changes in working practices?
We also look at novel, cross stake holder research partnerships – how is the science being done? How can the lab of the future be greener and deliver on corporate sustainability goals and targets? What is the new and emerging technology that will truly disrupt the way that we work and innovate?
The Live Lab sessions are returning to Lab of the Future Congress. Open floor debates with interactive whiteboards encourage the free flow of ideas on delivering the Lab of the Future. These sessions lead into the networking drinks reception.
Join for drinks and informal networking
There can be no greater mission than to achieve better health for our global citizens through innovation in medicine. How can we utilize technology and our internal research capabilities to translate our science into transformative medicines? How can we unify platforms and processes within the Lab of the Future to enable our scientists to deliver on this mission?
How do implement and roll out a data-rich experimentation workflow using existing and novel technologies? How can we work together to identify and integrate novel technologies that enables our scientists to bring innovative medicines to patients faster?
The second day of our digital lab workstream will include case studies on multi-stakeholder collaboration, developing a computational infrastructure for digital pathology and cross enterprise digitalization.
The second day of our Connected Lab work stream will focus on addressing the operational challenges in creating bring the connected lab to life. How can we give intelligence to laboratory instruments and allows data communication within an organisation? What is the role of the instrument vendors? What is the role of big tech? What early wins are we seeing and what challenges remain?
Continuing day one themes with a focus on real estate and new technologies.
